MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

BDX · NYSE

Becton, Dickinson and Company

Health Care · Medical/Dental Instruments

Reference price$166.34As of Jul 28, 2026
Market capitalization$45.83B
52-week range$140.11–$213.08
S&P 500 portfolio weight0.07%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$161.00-3.2% vs. reference
Average$179.56+7.9% vs. reference
High$204.00+22.6% vs. reference
5 Buy4 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 6, 2026Jun 2026
Consensus EPS$3.146 estimates
Expected range$3.06–$3.22Low to high EPS
Sep 2026$12.62Street EPS consensus
Sep 2027$13.48Street EPS consensus
Sep 2028$14.38Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Sep 30, 2025.

MetricCurrentPrior
Revenue+8.2% YoY$21.84B$20.18B
Operating income$2.58B$2.4B
Net income$1.68B$1.71B
Operating cash flow$3.43B$3.84B
Capital expenditures($0.76B)($0.73B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

The Motley Fool

My Top Dividend Growth Stock to Buy in July and Hold Forever

BNK Invest

Becton, Dickinson Now #262 Largest Company, Surpassing Block

The Motley Fool

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.